BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • BCI
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Saturday, July 11, 2026
Home » Authors » Stacy Lawrence

Articles by Stacy Lawrence

Researchers develop first test to detect active TB infection in urine

Dec. 27, 2017
By Stacy Lawrence
An estimated one-third of the world's population is infected with tuberculosis, with active infections typically emerging in the most vulnerable populations such as those with HIV, malnutrition or diabetes. It's one of the most common bacterial infections – and is among the most common causes of death worldwide, second only to HIV/AIDS as a deadly infectious disease.
Read More

First test developed to detect active TB infection in urine

Dec. 22, 2017
By Stacy Lawrence

Luna DNA formed to build genomic database powered by cryptocurrency

Dec. 21, 2017
By Stacy Lawrence

Bigfoot gets $37M to advance artificial pancreas into pivotal trial, smart insulin pen into clinic

Dec. 19, 2017
By Stacy Lawrence
Milpitas, Calif.-based Bigfoot Biomedical Inc. has raised $37 million in an initial tranche of a series B round to advance its development and clinical testing of a pair of diabetes products. These include an infusion pump-based, closed-loop, automated insulin delivery system, known as Bigfoot Loop, and an auto-titrating, connected, insulin pen-based system, known as Bigfoot Inject.
Read More

San Diego startup launches first smartphone-connected insulin pen with dose guidance

Dec. 18, 2017
By Stacy Lawrence

Study finds AI can be better than pathologists at spotting cancer spread to lymph nodes

Dec. 15, 2017
By Stacy Lawrence

Study finds AI can be better than pathologists at spotting cancer spread to lymph nodes

Dec. 15, 2017
By Stacy Lawrence
Given the ever-present hype around artificial intelligence (AI) as transformative to entire industries, including health care, it’s always useful to take a close look at the data. One of the latest efforts on that front was an analysis of several competing deep learning algorithms used to detect the spread of breast cancer to the lymph nodes that was recently published in the Journal of the American Medical Association (JAMA).
Read More

S&N launches wound-imaging handheld in ex-U.S., aims for FDA approval in spring 2018

Dec. 13, 2017
By Stacy Lawrence

Scientists show new brain connection, use low frequency stimulation to aid cognition in PD

Dec. 4, 2017
By Stacy Lawrence

Alivecor EKG band wins first FDA nod for Apple Watch-based medical device

Dec. 1, 2017
By Stacy Lawrence
The long-eroding boundary between consumer and medical devices has been definitely crossed. After a review of about a year and a half, the FDA has cleared the wrist-worn Kardia Band from Alivecor Inc. for the Apple Watch that can take a medical-grade electrocardiogram (EKG) in 30 seconds as the user touches it with a thumb.
Read More
Previous 1 2 … 55 56 57 58 59 60 61 62 63 … 80 81 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for July 10, 2026.
  • 3D rendering of an antibody drug conjugate

    ‘Target-high but uptake-defective’ state identified in ADC resistance

    BioWorld
    Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
  • Wainua autoinjector

    Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy

    BioWorld
    News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
  • Art concept for medical research

    FENS 2026: Shedding light on the sheddome

    BioWorld
    At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
  • Silhouette with keyhole

    FENS 2026: Next-gen biologics take on brain disease

    BioWorld
    Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing